-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Drug safety is a people's livelihood project and a people-friendly project
.
In order to further ensure the quality and safety of drugs, since the beginning of this year, many places have issued documents one after another, clearly expressing the need to strengthen the construction of drug supervision capacity and promote the high-quality development of the pharmaceutical industry
.
Henan A few days ago, the General Office of the People's Government of Henan Province announced "Several Measures for Comprehensively Strengthening Drug Regulatory Capacity Building in Henan Province" (hereinafter referred to as "Measures")
.
The "Measures" put forward 23 specific measures for capacity building in 7 aspects, aiming to further promote the high-quality development of the pharmaceutical industry in Henan Province
.
The "Measures" aim to improve the ability of standardized management, improve regulations and standards; improve the ability of review and approval to stimulate the vitality of industrial development; improve the ability of inspection and law enforcement, and promote the efficient coordination of supervision; improve the ability of inspection and testing, improve the technical support system; Strengthening risk research, judgment and disposal; improving innovative supervision capabilities to help empower the whole process of supervision; improving basic guarantee capabilities and strengthening policy and talent support
.
Beijing Recently, Beijing issued a policy document "Several Measures to Comprehensively Strengthen the Construction of Drug Regulatory Capacity in Beijing", a policy document specifically aimed at building drug regulatory capacity.
The "Measures" consists of 9 parts and 24 measures, involving 7 systems and 2 capabilities.
.
It is understood that the "Measures" propose that the city will establish innovative service channels to serve and promote the research and development of innovative products in terms of improving the review and testing system with the capital's characteristics; at the same time, it will create the capital's "two products and one machine" inspection and testing capabilities
.
In addition, the "Measures" also proposed that the city will improve the innovative and convenient smart supervision system by improving the information traceability system, deepening the digital management of the whole life cycle, and improving the application service level of "Internet + supervision"
.
And accelerate the innovation of traditional Chinese medicine, promote the innovation of the pharmaceutical and health industry, implement the scientific action plan for drug supervision, promote the coordinated development of drug safety in Beijing-Tianjin-Hebei, and at the same time improve the level of internationalization of supervision
.
Shaanxi The General Office of the Shaanxi Provincial Government also issued "Several Measures for Comprehensively Strengthening the Construction of Drug Supervision Capacity in Shaanxi Province" (hereinafter referred to as "Measures") some time ago, to comprehensively strengthen the construction of drug supervision capacity in Shaanxi and improve the level of drug supervision
.
The "Measures" pointed out that Shaanxi will conscientiously implement the "four strictest" requirements, and improve the "six major systems" of drug regulatory systems and mechanisms, vaccine management and operation, risk prevention and control, social co-governance, emergency response, and safe development and win-win.
Accelerate the promotion of institutional substantiation, team specialization, management informatization, and closed-loop work to provide a strong guarantee for the high-quality economic and social development of Shaanxi
.
Conclusion In addition to the above provinces and cities, some time ago, Gansu, Shanxi, Jiangxi and other places have also issued relevant documents that can suit their own development and strengthen their drug regulatory capabilities
.
In this regard, the analysis believes that these documents will further improve the local drug supervision system, strengthen team building, promote supervision innovation, and will also provide important guidelines for the overall promotion of the modernization of local drug supervision
.
However, it should be noted that at the same time, the pharmaceutical industry will also face stricter standards, stricter supervision, stricter penalties, and more serious accountability
.
Affected by this, the domestic drug regulatory capacity building may reach a new level, and it will help the pharmaceutical industry to accelerate its development towards higher quality
.
Disclaimer: Under no circumstances does the information or opinions expressed in this article constitute investment advice to anyone
.
.
In order to further ensure the quality and safety of drugs, since the beginning of this year, many places have issued documents one after another, clearly expressing the need to strengthen the construction of drug supervision capacity and promote the high-quality development of the pharmaceutical industry
.
Henan A few days ago, the General Office of the People's Government of Henan Province announced "Several Measures for Comprehensively Strengthening Drug Regulatory Capacity Building in Henan Province" (hereinafter referred to as "Measures")
.
The "Measures" put forward 23 specific measures for capacity building in 7 aspects, aiming to further promote the high-quality development of the pharmaceutical industry in Henan Province
.
The "Measures" aim to improve the ability of standardized management, improve regulations and standards; improve the ability of review and approval to stimulate the vitality of industrial development; improve the ability of inspection and law enforcement, and promote the efficient coordination of supervision; improve the ability of inspection and testing, improve the technical support system; Strengthening risk research, judgment and disposal; improving innovative supervision capabilities to help empower the whole process of supervision; improving basic guarantee capabilities and strengthening policy and talent support
.
Beijing Recently, Beijing issued a policy document "Several Measures to Comprehensively Strengthen the Construction of Drug Regulatory Capacity in Beijing", a policy document specifically aimed at building drug regulatory capacity.
The "Measures" consists of 9 parts and 24 measures, involving 7 systems and 2 capabilities.
.
It is understood that the "Measures" propose that the city will establish innovative service channels to serve and promote the research and development of innovative products in terms of improving the review and testing system with the capital's characteristics; at the same time, it will create the capital's "two products and one machine" inspection and testing capabilities
.
In addition, the "Measures" also proposed that the city will improve the innovative and convenient smart supervision system by improving the information traceability system, deepening the digital management of the whole life cycle, and improving the application service level of "Internet + supervision"
.
And accelerate the innovation of traditional Chinese medicine, promote the innovation of the pharmaceutical and health industry, implement the scientific action plan for drug supervision, promote the coordinated development of drug safety in Beijing-Tianjin-Hebei, and at the same time improve the level of internationalization of supervision
.
Shaanxi The General Office of the Shaanxi Provincial Government also issued "Several Measures for Comprehensively Strengthening the Construction of Drug Supervision Capacity in Shaanxi Province" (hereinafter referred to as "Measures") some time ago, to comprehensively strengthen the construction of drug supervision capacity in Shaanxi and improve the level of drug supervision
.
The "Measures" pointed out that Shaanxi will conscientiously implement the "four strictest" requirements, and improve the "six major systems" of drug regulatory systems and mechanisms, vaccine management and operation, risk prevention and control, social co-governance, emergency response, and safe development and win-win.
Accelerate the promotion of institutional substantiation, team specialization, management informatization, and closed-loop work to provide a strong guarantee for the high-quality economic and social development of Shaanxi
.
Conclusion In addition to the above provinces and cities, some time ago, Gansu, Shanxi, Jiangxi and other places have also issued relevant documents that can suit their own development and strengthen their drug regulatory capabilities
.
In this regard, the analysis believes that these documents will further improve the local drug supervision system, strengthen team building, promote supervision innovation, and will also provide important guidelines for the overall promotion of the modernization of local drug supervision
.
However, it should be noted that at the same time, the pharmaceutical industry will also face stricter standards, stricter supervision, stricter penalties, and more serious accountability
.
Affected by this, the domestic drug regulatory capacity building may reach a new level, and it will help the pharmaceutical industry to accelerate its development towards higher quality
.
Disclaimer: Under no circumstances does the information or opinions expressed in this article constitute investment advice to anyone
.
